跳至主要内容
临床试验/NL-OMON35457
NL-OMON35457已完成4 期

Immune respons after inactivated oral cholera vaccination (Dukoral) in kidneytransplant recipients. Mucosal immune response in ImmunoCompromised Host (MICH) - MICH

eids Universitair Medisch Centrum0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >= 18 years
  • - Creatinin clearance >= 40 ml/min
  • - Stable renal function for 1 year prior to inclusion
  • - Stabe immunosuppressive medication for 3 months prior to inclusion, consisting of prednisone in combination with either a calcineurine inhibitor, mycophenolate mofetil or an mTOR inhibitor

排除标准

  • - A chronic disease which may influence the immune system, other than the renal transplant and accompanying immunosupressive medication
  • - Chronic infection
  • - Treatment for graft rejection in the year prior to inclusion
  • - Prior vaccination with Dukoral or another oral cholera or ETEC vaccine.
  • - Prior Vibrio cholerae infection
  • - Travellers' diarrhea 6 months prior to inclusion
  • - Known allergy to the vaccine or to one of the vaccine components
  • - History of an anaphylactic reaction following vaccination
  • - Treatment with plasma or blood products in the 3 months prior to inclusion
  • - Pregnancy or breast feeding
  • - Immunosuppressive medication other than prednisone, a calcineurine inhibitor, mycophenolate mofetil or an mTOR inhibitor

研究者

相似试验